SymBio Pharmaceuticals Ltd SYMQY
$0.56
Last Updated: Jan 30, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
SYMQY Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, SymBio Pharmaceuticals Ltd is classified as halal.
HALAL
Report Source: undefined Quarter Report
SymBio Pharmaceuticals Ltd. Stock Analysis SYMQY
United States Health Care Nano Cap SymBio Pharmaceuticals Ltd. engages in the pharmaceutical business. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 91 full-time employees. The company went IPO on 2011-10-20. Along with medicine specialists, contract research organizations (CROs) and other pharmaceutical companies, the Company is engaged in the design and operation of clinical tests, the manufacture and sale of new drugs specializing in three therapeutic areas: cancer, blood diseases and autoimmune diseases. The firm develops new medicines using chemical compounds proofed by preclinical tests and clinical tests. The firm manufactures and sells medicines through domestic and foreign pharmaceutical companies. The firm's pipelines include anticancer drugs, such as SyB L-0501, SyB L-1101 and SyB C-1101.
SymBio Pharmaceuticals Ltd (SYMQY) Chart
Financial Metrics & Statements of SymBio Pharmaceuticals Ltd (SYMQY)
FAQ's for SymBio Pharmaceuticals Ltd (SYMQY)
- As of August 2026, SymBio Pharmaceuticals Ltd SYMQY is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes SymBio Pharmaceuticals Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in SymBio Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of SymBio Pharmaceuticals Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of SymBio Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of SymBio Pharmaceuticals Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to SymBio Pharmaceuticals Ltd (SYMQY)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
